New Drug May Help Control Hypo Risks

| Aug 1, 1998

Heralded as the best thing since insulin, pramilitide, a new drug being studied by two U.S. research centers, may soon be available to help type 1 individuals reduce hypoglycemia risks. The St. James Center for Diabetes in Chicago and Tulane University Medical Center in New Orleans both recently launched studies of the drug's effectiveness in improving glucose control and lessening the risk of hypoglycemia in type 1 patients. In preliminary studies, patients not only improved glucose control while using pramilitide, but had better cholesterol profiles and lost weight. The current studies seek to confirm the earlier findings.

Both the St. James Center and Tulane University are currently seeking candidates to participate in their studies. Participants must have been taking insulin for at least 12 months, be in good health, have had a stable insulin regimen for the past two months, and be willing to take additional injections of the experimental drug as an adjunct to insulin.

Contact Robyn Ekings in New Orleans at (504) 588-5221 or Christine Beebe in Chicago at (708) 709-2010 for more information.

Click Here To View Or Post Comments

Categories: Diabetes, Hypoglycemia Unawareness, Insulin, Low Blood Sugar

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Aug 1, 1998

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.